Item 5.07 Submission of Matters to a Vote of Security Holders.

Constellation Pharmaceuticals, Inc. (the "Company") held its Annual Meeting of Stockholders on June 2, 2021. The following is a summary of the matters voted on at that meeting.





1.   The Company's stockholders elected Scott N. Braunstein, Mark A. Goldsmith,
     and Jigar Raythatha as Class III directors, each to serve for a three-year
     term expiring at the 2024 Annual Meeting of Stockholders. The results of the
     stockholders' votes with respect to the election of such Class III directors
     were as follows:




                       Votes For        Votes Withheld       Broker Non-Votes
Scott N. Braunstein     25,260,234           17,780,668              1,679,062
Mark A. Goldsmith       27,987,099           15,053,803              1,679,062
Jigar Raythatha         36,231,475            6,809,426              1,679,062




2.   A non-binding, advisory proposal on the compensation of the Company's named
     executive officers was approved.




Votes For    Votes Against   Votes Abstaining   Broker Non-Votes
41,308,464     1,731,674           764             1,679,062




3.   The shareholders recommended, in a non-binding, advisory vote, that future
     advisory votes on the compensation of the Company's named executive officers
     be held every year.




Every 1 Year   Every 2 Years   Every 3 Years   Abstain   Broker Non-Votes
 43,028,341        9,482           1,963        1,116       1,679,062




4.   The Company's stockholders ratified the appointment of Ernst & Young LLP as
     the Company's independent registered public accounting firm for the fiscal
     year ending December 31, 2021. The results of the stockholders' vote with
     respect to such ratification were as follows:




Votes For    Votes Against   Votes Abstaining   Broker Non-Votes
44,682,854      27,828            9,282                0

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses